Kevin Carroll

3.3k citations
29 papers · 2.3k indexed · 1 hit paper · h-index 9
Topics
Renal Diseases and Glomerulopathies (9 papers)Statistical Methods in Clinical Trials (5 papers)Chronic Kidney Disease and Diabetes (3 papers)

In The Last Decade

Kevin Carroll

26 papers receiving 2.2k citations

Hit Papers

Gefitinib plus best supportive care in previously treated...2005202620122019200550010001.5k

Peers

Kevin Carroll
Comparison fields: 5 of 86
  • Pulmonary and Respiratory Medicine 1.5k
  • Oncology 1.3k
  • Molecular Biology 396
  • Cardiology and Cardiovascular Medicine 283
  • Cancer Research 275
Replace Xiaolei Zhu with:
Xiaolei Zhu China
Eunsik Lee South Korea
Eugene R. Ahn United States
Yazdi K. Pithavala United States
Grazyna Liebérman United States
Jamal Tarazi United States
Young Hak Kim Japan
Lauren McCann United States
Pamela Salman Chile
Pascaline Boudou‐Rouquette France
Kevin Carroll relative to Xiaolei Zhu China Xiaolei Zhu's profile →
Citations per field
00.5×1.5×2.2×
Xiaolei Zhu · 1×
Citations per year

Countries citing papers authored by Kevin Carroll

Since Specialization
Citations

This map shows the geographic impact of Kevin Carroll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Carroll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Carroll more than expected).

Fields of papers citing papers by Kevin Carroll

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Carroll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Carroll. The network helps show where Kevin Carroll may publish in the future.

Co-authorship network of co-authors of Kevin Carroll

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Carroll. A scholar is included among the top collaborators of Kevin Carroll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Carroll. Kevin Carroll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 2
4 1
5 2
6 2
7 8
8 2
9 2
10 3
11 7
12 161
13 2
14 1
15 1
16 8
17 287
18 5
19 19
20
Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)breakdown →
1688

About Kevin Carroll

Kevin Carroll is a scholar working on Nephrology, Health Informatics and Statistics and Probability, having authored 29 papers that have together received 2.3k indexed citations. Recurring topics across this work include Renal Diseases and Glomerulopathies (9 papers), Statistical Methods in Clinical Trials (5 papers) and Chronic Kidney Disease and Diabetes (3 papers). The work is most often cited by research in Oncology (1.3k citations), Pulmonary and Respiratory Medicine (1.5k citations) and Nephrology (193 citations). Kevin Carroll has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Kristine Pemberton, Sumitra Thongprasert, Venice Archer, Nick Thatcher, Purvish M. Parikh, Joachim von Pawel, Alex Y. Chang, E.H. Tan, Tudor–Eliade Ciuleanu and José Rodrigues Pereira. Their work appears in journals such as The Lancet, Circulation and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026